Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

about

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

Item

http://www.wikidata.org/entity/Q43441552

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@en

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@nl

type

Item

label

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@en

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@nl

prefLabel

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@en

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.

@nl

P1476

Alterations in thyroid function among the different polycystic ovary syndrome phenotypes

@en

P2093

Maria Concetta Musacchio

http://www.w3.org/2001/XMLSchema#string

Maria Giulia Massaro

http://www.w3.org/2001/XMLSchema#string

Raoul Orvieto

http://www.w3.org/2001/XMLSchema#string

P2860

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy.

Genetic and environmental origins of obesity relevant to reproduction.

TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients.

Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome.

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.

Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.

Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.

High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome.

P304

967-969

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09513590.2013.829445

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo De Leo

Giuseppe Morgante

P577

2013-08-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23957782

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome